News from MAX IV

Glowing molecular structure in futuristic galaxy backdrop generated by AI

New anti-cancer candidate revealed with AI drug screening and X-rays

Consider it a success case or a bright point of discovery in the search for cancer inhibitors. An international team of researchers has identified a new compound to potentially disarm AKR1C3, an upregulated enzyme found in prostate, breast and other cancers, using AI-based drug screening and brilliant X-ray light at MAX IV. Is this study a diamond in the rough or a glimpse of more to come in biomedical research using artificial intelligence?

Guided by the light?

Come work with us!

The opportunity to a be part of building MAX IV is for many enough reason to join our team. But aside from tinkering with all our stunning technology, we also offer a wide array of benefits to everyone of our employees.

Vacancies at MAX IV chevron_right